Perbedaan Minahasa Membangun Hebat Tbk. dan Merck Tbk.: Minahasa Membangun Hebat Tbk. diperdagangkan di Rp272 (kapitalisasi pasar 285,16 M, volume 24 jam 4,43 jt), sedangkan Merck Tbk. diperdagangkan di Rp3.800 (kapitalisasi pasar 1,68 T, volume 24 jam 33,3 rb). Perbedaan utamanya: Merck Tbk. jauh lebih besar — sekitar 5,9× kapitalisasi pasar Minahasa Membangun Hebat Tbk., dan Minahasa Membangun Hebat Tbk. lebih aktif diperdagangkan (4,43 jt vs 33,3 rb). Mana yang lebih baik tergantung tujuan investasimu.
| HBAT | MERK | |
|---|---|---|
Kapitalisasi Pasar | 285,16 M | 1,68 T |
Volume | 4,43 jt | 33,3 rb |
Lot | 44,33 rb | 333 |
Perputaran | 1,17 M | 126,46 jt |
Harga Rata-rata | 264,91 | 3.797,72 |
Nilai Transaksi | 1,17 M | 126,46 jt |
Harga Ekuilibrium Indikatif | 272 | 3.800 |
Volume Ekuilibrium Indikatif | 22 | 9 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Minahasa Membangun Hebat Tbk was established based on Notarial Deed No. 44 datedJanuary 31, 2020 of Dian Fitriana, S.H., M.Kn., a public notary in Bekasi.
Selengkapnya di halaman HBAT →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →